Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LFCR has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
LFCR stock price ended at $6.71 on Wednesday, after losing-1.47%
The Lifecore Biomedical Inc stock price decreased by -1.47% on the last trading day (18 Jun 2025), dropping from 6.8 to 6.71. Throughout the last trading session, the stock experienced a fluctuation of 1.87% , ranging from a day low of $6.675 to a day high of 6.8. The price has declined in 6 of the last 10 days, resulting in a total change of -2.47% during this period. On the last day, trading volume increase by -155.53K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 75.76K shares were traded, amounting to approximately 510.36K.
LFCR Technical Signals
LFCR(Lifecore Biomedical Inc Corp) has 1 buy signal and 6 sell signals now. The current trend is consolidation starting from 2025-06-11. The total price change during this trend is -0.74%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of LFCR over the last 5 trading days is 766.96K. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
LFCR Moving Average Analysis
Lifecore Biomedical Inc's overall moving average trend leans more bearish as of Friday, June 20, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $7.132126666666666, and $7.3116666666666665. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $6.5512066666666655, and $6.371666666666665. A break-down below any of these levels will issue sell signals.
LFCR Short Selling Analysis
The short sale ratio of Lifecore Biomedical Inc(LFCR) as of 17 Jun 2025 is 13.02%, dropping from last trading day. With decreasing price from 6.67 to 6.81. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
6
Buy
1
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0149
Bullish
6 Bearish Signals
6 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.0626
Bearish
Momentum (10 days)
MOM_10 < 0
-0.17
Bearish
Moving Average
Price crosses below 5-day SMA
--
Bearish
Moving Average
Price crosses below 10-day SMA
--
Bearish
Moving Average
Price crosses below 20-day SMA
--
Bearish
Moving Average
10-day SMA crosses below 20-day SMA
--
Bearish
LFCR Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Lifecore Biomedical Inc(LFCR), our algorithm predicts LFCR's 1-month price at $7.21, with an 6.57%upwardshift. Using a similarity score up to 94.37%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Lifecore Biomedical Inc (LFCR.O) stock, as of Sunday, June 1, 2025 , forecasts a 6.57% change over the next month, based on its high correlation with BIIB.O stock patterns. The similarity between their price movements over the analyzed periods is 94.37%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
LFCR
No Data
BIIB
Up: 6.57%Similarity: 94.37%
Name
Similarity
Up/Down
BIIB.O
94.37%
+6.57%
SIG.N
93.89%
-2.36%
VNDA.O
93.81%
+4.56%
SRE.N
93.31%
+5.07%
AME.N
92.91%
+13.78%
WHR.N
92.75%
+0.88%
BRC.N
92.55%
+4.64%
SCNI.O
92.31%
-4.01%
FLL.O
92.28%
-4.15%
HURA.O
92.27%
+0.74%
LFCR Seasonality Analysis
Based on LFCR's historical stock price data across all years, the probability of a positive return in June is45.45%, suggesting it maynotbe an ideal month to invest in LFCR. In contrast,Apriloffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Lifecore Biomedical Inc (LFCR.O) stock in April has the highest probability of a positive return (72.73%), while September has the lowest probability (30.00%).
Performance Seasonality
The chart shows Lifecore Biomedical Inc. (LFCR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Lifecore Biomedical Inc (LFCR.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LFCR has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Lifecore Biomedical Inc (LFCR.O) stock in a year?
The radar chart shows that buying Lifecore Biomedical Inc (LFCR.O) stock in April has the highest probability of a positive return (72.73%), while September has the lowest probability (30.00%).
How has Lifecore Biomedical Inc. (LFCR)'s stock price performed over the past three years?
LFCR's stock price fell by -2.52% in 2023,increased by 16.46% in 2024, and went up by 0.75% in 2025.
Which bull technical signals does LFCR have?
Bullish technical signals of LFCR include: MACD_12_26_9 > 0.
Is LFCR a buy based on overall technical signals summary?
LFCR has 1 buy signals and 6 sell signals now. Overall the technical rating for LFCR is Strong sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of LFCR.
What is the trend of Lifecore Biomedical Inc (LFCR)'s moving average?
Lifecore Biomedical Inc's overall moving average trend leans more bearish as of June 20 2025, with 2 negative signals and 2 positive signal.
What is price prediction for LFCR stock next month?
The price prediction chart for Lifecore Biomedical Inc (LFCR.O) stock, as of June 01 2025, forecasts a 6.57% change over the next month, based on its high correlation with BIIB stock patterns. The similarity between their price movements over the analyzed periods is 94.37%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for LFCR Stock?
Lifecore Biomedical (LFCR) stock is predicted to reach **$7.20 by year-end 2025**, driven by its strong CDMO pipeline expansion and new customer agreements. However, the stock faces resistance at Fibonacci levels of $7.14 and $7.32, which may limit upside.
What is price prediction 2030 for LFCR Stock?
LFCR stock is predicted to reach **$12.00 to $15.00 by 2030**, driven by strong institutional interest and new customer agreements. The stock currently trades at $6.78, with a bullish outlook supported by William Blair's Outperform recommendation and a 58.39% upside target of $10.20.